Latest Options News

Western Mines Group has completed its Phase 3 drilling at the Mulga Tank Project, revealing extensive nickel sulphide mineralisation and securing a royalty extinguishment that enhances project value. The company also raised over $1.2 million to advance exploration.

Avira Resources reports significant progress in its Swedish Puolalaki Project with ongoing farm-out talks and secures a new tenement in Western Australia’s Tangadee Project, while preparing a capital raise to fund exploration.

Matsa Resources has secured $3.13 million through a share placement to fast-track mining operations at its Devon Pit Gold Mine, backed by major shareholders and a new sophisticated investor.

Charger Metals NL reports significant progress in its lithium exploration projects at Lake Johnston and Bynoe, backed by Rio Tinto's funding and a recent $0.77 million capital raise. Upcoming assay results and drilling programs could shape the company’s growth trajectory.

RLG Ltd has successfully raised $900,000 through a two-tranche placement to fund the development of its food and health products and expand global sales channels. The second tranche, involving options issuance, awaits shareholder approval.

Terra Uranium has significantly expanded its land holdings in the Athabasca Basin through strategic option agreements with ATHA Energy Corp, setting the stage for a robust 2025 drilling campaign amid a recovering uranium market.

Cyprium Metals has secured $13.5 million in a two-tranche placement and released a robust prefeasibility study for its Nifty Copper Complex, confirming strong economic viability with a pre-tax NPV of $1.12 billion. The company is also reviewing its Murchison assets and selling surplus equipment to streamline operations.

Aumake Limited reported a remarkable 239% increase in quarterly cash receipts, driven by a $16 million purchase order from Yangtze River and a strategic capital raise, positioning the company for robust growth in 2025.

Bellavista Resources has secured nearly A$5 million in capital to fund due diligence on advanced precious and base metal projects, while maintaining a strong cash position and progressing exploration at its Brumby Deposit.

FirstWave reports a stable Q2 FY25 with no cash burn for the second consecutive quarter, maintaining cash reserves at $1.68 million while securing key client contract renewals and launching a promising new product.

FirstWave Cloud Technology reports a cashflow positive first half of FY25, driven by strategic contract renewals and new technology launches, despite a slight decline in recurring revenue due to customer churn.

Argenica Therapeutics has dosed 80% of patients in its Phase 2 stroke trial and gained FDA orphan drug designations for its second candidate, ARG-006. The company reports a cash-positive quarter with $15 million in reserves.